Epigenetic modulation inhibits epithelial-mesenchymal transition-driven fibrogenesis and enhances characteristics of chemically-derived hepatic progenitors
Open Access
- 1 January 2024
- journal article
- research article
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 106 (5) , 274-283
Abstract
Adisasmita M, et al. Ann Surg Treat Res. 2024 May;106(5):274-283. https://doi.org/10.4174/astr.2024.106.5.274Keywords
This publication has 28 references indexed in Scilit:
- Human chemically-derived hepatic progenitors (hCdHs) as a source of liver organoid generation: Application in regenerative medicine, disease modeling, and toxicology testingBiomaterials, 2023
- Improving the repopulation capacity of elderly human hepatocytes by decoding aging‐associated hepatocyte plasticityHepatology, 2022
- Transplantation of patient‐specific bile duct bioengineered with chemically reprogrammed and microtopographically differentiated cellsBioengineering & Translational Medicine, 2021
- The Role of Complement in Liver Injury, Regeneration, and TransplantationHepatology, 2019
- Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cellsJournal of Hepatology, 2019
- Liver regeneration requires Yap1-TGFβ-dependent epithelial-mesenchymal transition in hepatocytesJournal of Hepatology, 2018
- Epigenetics: A primer for cliniciansBlood Reviews, 2016
- Sox9 regulates self‐renewal and tumorigenicity by promoting symmetrical cell division of cancer stem cells in hepatocellular carcinomaHepatology, 2016
- Epigenetics in liver diseaseHepatology, 2014
- Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor MetastasisDevelopmental Cell, 2008